Aduhelm OverviewAducanumab, sold under the brand name Aduhelm, is a medication used to treat Alzheimer's disease (AD). It is an amyloid beta-directed monoclonal antibody. Aducanumab targets aggregated forms of Amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. Aducanumab was approved for medical use in the United States in June 2021, and it represents a first-of-its...
Read more Aduhelm Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aducanumab
Recent Aduhelm Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 170mg/1.7ml (100mg/ml), 300mg/3ml (100mg/ml)
NDC Database Records for Aduhelm: (2 results)Sorted by National Drug Code
- 64406-101 Aduhelm 100 mg/ml Intravenous Injection, Solution by Biogen Inc.
- 64406-102 Aduhelm 100 mg/ml Intravenous Injection, Solution by Biogen Inc.